3895 results for «2025»
3895 results
PCR Global Interventional Academy
20 May 2026
This one-of-a-kind academy offers independent, cutting-edge training pathways for ambitious interventionalists who have been in practice for a few years and are looking to grow - both personally and professionally. Two recurrent high-level one-year tracks on coronary interventions and TAVI are already underway, with further opportunities forecast for...
PCR Seminars 2024: education brought to your doorstep!
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.

Author
Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR
06 Aug 2025
Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target
07 Oct 2025
Foldax announces positive one-year data on TRIA Mitral Valve
27 Jun 2025
Siemens Healthineers introduces industry-first seamlessly integrated end-to-end solution for CT-guided percutaneous coronary interventions
19 May 2026
TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation
31 Mar 2026
Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Author
Bentley acquired the GoBack catheter
13 Sep 2022
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR
09 Mar 2026
Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Author

Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Author
SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial
16 Aug 2024
Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference
28 Oct 2024
BIOSOLVE-IV full-cohort two-year data confirm excellent safety and efficacy profile of Magmaris resorbable magnesium scaffold
23 Sep 2022
First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR
09 Sep 2022
Quadruple pulmonary vein stenting for post-ablation stenosis
28 Apr 2025
Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Author
Elixir Medical announces launch of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe
09 Apr 2025
Prompt intervention for severe aortic stenosis patients demonstrates lower healthcare costs, improved clinical outcomes
22 May 2025